Scott Bizily
Vermogen: 87 721 $ op 31-07-2026
Vermogen: 87 721 $ op 31-07-2026
Dr. Scott P.
Bizily is a Secretary, Chief Compliance & Legal Officer at 4D Molecular Therapeutics, Inc. Dr. Bizily was previously employed as a General Counsel by Synthego Corp.
and a Director-Corporate Counsel by BioMarin Pharmaceutical, Inc. He received his graduate degree from the University of Pennsylvania and a doctorate degree from the University of Georgia.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-08-2026 | 8.617 ( 0,02% ) | 87 721 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Compliance Officer | 01-12-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Engages in research, development and manufactures CRISPR cell & gene therapies | Algemeen Adviseur | 01-09-2021 |
| BIOMARIN PHARMACEUTICAL INC. | Algemeen Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Engages in research, development and manufactures CRISPR cell & gene therapies | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau